Reduced Risk of Hepatitis B and Hepatitis C Among Injection Drug Users in the Tacoma Syringe Exchange Program.

American Journal of Public Health - United States
doi 10.2105/ajph.85.11.1531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Public Health Association

Related search

Seroepidemiology and Risk Factors of Hepatitis B and C Virus Infections Among Drug Users in Jakarta, Indonesia

Medical Journal of Indonesia
Medicine
2002English

The Relationship Between Social Network Factors, HIV, and Hepatitis C Among Injection Drug Users in Chennai, India

Drug and Alcohol Dependence
PsychiatryToxicologyMental HealthPharmacology
2011English

Comparison of the Mechanisms of Drug Resistance Among HIV, Hepatitis B, and Hepatitis C

Viruses
VirologyInfectious Diseases
2010English

The Role of Syringe Filters in Harm Reduction Among Injection Drug Users.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1999English

Reinfection With Hepatitis C Virus Following Sustained Virological Response in Injection Drug Users

Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2010English

AIDS Risk Reduction and Reduced HIV Seroconversion Among Injection Drug Users in Bangkok.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1994English

Estimation of the Secondary Attack Rate for Delta Hepatitis Coinfection Among Injection Drug Users

Canadian Journal of Infectious Diseases
1993English

Prevalence of Human Immunodeficiency Virus and Hepatitis (B & C) Among Drug Users in a Tertiary Care Public Hospital

Pakistan Journal of Medical Sciences
Medicine
2019English

Hepatitis C Virus Risk Behaviors Within the Partnerships of Young Injecting Drug Users

Addiction
MedicinePsychiatryMental Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy